Baudax Bio Announces the Cancellation of Adjourned Portion of Annual Shareholder Meeting

May 28, 2021 4:05pm EDT

Baudax Bio to Present at the 2021 Jefferies Virtual Healthcare Conference

May 27, 2021 7:00am EDT

Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management

May 17, 2021 7:00am EDT

Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote "For" the Proposed Additional Authorized Shares

May 13, 2021 7:00am EDT

Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote "For" The Additional Authorized Shares

May 12, 2021 9:02am EDT

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

May 11, 2021 4:05pm EDT

Baudax Bio Reports First Quarter 2021 Financial Results

May 05, 2021 7:00am EDT

Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021

Apr 29, 2021 7:00am EDT

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

Apr 26, 2021 7:00am EDT

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

Apr 08, 2021 4:05pm EDT